Printer Friendly

S.R. (BOB) BLAIR TO JOIN BOARD OF DIRECTORS OF BIOMIRA INC.

 S.R. (BOB) BLAIR TO JOIN BOARD OF DIRECTORS OF BIOMIRA INC.
 EDMONTON, Alberta, Feb. 18 /PRNewswire/ -- Eric E. Baker, chairman of the board of directors of Biomira Inc. (Toronto, Montreal, Calgary: BRA), today announced that S.R. (Bob) Blair will join the board of directors of Biomira effective immediately.
 Blair, an engineer by profession, is chairman emeritus of NOVA Corp. of Alberta, based in Calgary, Alberta. He serves as adjunct full professor of the Department of Environmental Design at the University of Calgary. The recipient of numerous awards and honours, he was named Officer, The Order of Canada in 1980 and received the prestigious Companion, The Order of Canada in 1985. In 1990, he was given the honorary title of chief of the Blackfoot Indian Confederacy.
 In announcing the appointment Baker stated, "We are pleased that Mr. Blair, a visionary entrepreneur and highly successful businessman, has agreed to join our board. His vast experience will certainly complement the composition of our board."
 Biomira Inc. is a public biotechnology company focused on the research, development and commercialization of cancer diagnostic and therapeutic products. The firm, located in Edmonton Research Park, currently markets four in vitro diagnostic kits for gastrointestinal, ovarian and breast cancers under the TRUQUANT(R) label. A number of its in vivo products are in various stages of clinical trials.
 -0- 2/18/92
 /CONTACT: Alex McPherson, M.D., Ph.D., president and CEO of Biomira Inc., 403-450-3761/
 (BIOMF BRA.) CO: Biomira Inc. ST: Alberta IN: MTC SU: PER


AL-JL -- LA030 -- 0207 02/18/92 18:40 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 18, 1992
Words:260
Previous Article:NORTH SIDE SAVINGS BANK REPORTS ON PROGRESS OF CONSOLIDATION AND SALE OF DEPOSITS ACQUIRED FROM THE RTC
Next Article:KATY INDUSTRIES REPORTS LOSS FOR FOURTH QUARTER
Topics:


Related Articles
BIOMIRA INC. ANNOUNCES NASDAQ LISTING
BIOMIRA ANNOUNCES COMPLETION OF PUBLIC OFFERING
BIOMIRA INC. ANNOUNCES THAT TWO OF ITS FOUNDERS SELL SMALL PORTION OF THEIR SHARES
BIOMIRA INC. ANNOUNCES REGULATORY APPROVAL FOR CLINICAL TRIALS IN GERMANY
RIBI IMMUNOCHEM LICENSES MELACINE MELANOMA THERACCINE TO BIOMIRA INC. EXCLUSIVELY IN CANADA
BIOMIRA INC. ANNOUNCES COMPLETION OF CANADIAN PUBLIC OFFERING
BIOMIRA INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH AUSTRALIAN NUCLEAR SCIENCE & TECHNOLOGY ORGANISATION
BIOMIRA ANNOUNCES PLANS TO CONDUCT ADDITIONAL PHASE II CLINICAL TRIAL ON TRU-SCINT(R) AD(TM)
BIOMIRA ESTABLISHES SECOND LICENSE AGREEMENT WITH BEHRINGWERKE A.G.
Genetronics Announces Canadian Pharmaceutical, Biotechnology Executive Joins Its Board of Directors

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters